| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.28B | +54.9% |
| R&D Expense | $7.3M | +9.0% |
| SG&A Expense | $58.4M | -21.0% |
| Operating Income | $2.5M | +101.9% |
| Pre-tax Income | $21.1M | +118.3% |
| Income Tax | $41.2M | +153.6% |
| Net Income | -$20.1M | +84.7% |
| EPS (Basic) | -$0.18 | +89.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $214.8M | -8.8% |
| Accounts Receivable | $419.2M | +31.3% |
| Inventory | $153.7M | +22.9% |
| Current Assets | $865.5M | +13.3% |
| Total Assets | $1.94B | +4.4% |
| Current Liabilities | $437.7M | +32.2% |
| Total Liabilities | $651.3M | +16.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $80.2M | +396.6% |
| Capital Expenditures | $81.9M | +0.5% |
| Investing Cash Flow | -$71.2M | -163.6% |
| Financing Cash Flow | -$25.6M | -256.9% |
| Free Cash Flow | -$1.7M | +97.3% |
| Stockholders' Equity |
| $1.29B |
| -0.9% |